Market Tracker

08/19 6:05pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

68.05
Data as of Aug 19
 +0.83 / +1.23%
Today’s Change
46.72
Today|||52-Week Range
112.57
+5.83%
Year-to-Date

Today’s Trading

Previous close67.22
Today’s open67.68
Day’s range66.46 - 68.50
Volume392,212
Average volume (3 months)755,266
Market cap$5.1B
Dividend yield--
Data as of 3:59pm ET, 08/19/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-270.52%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book15.85

Competitors

 Today’s
change
Today’s
% change
CBSTCubist Pharmaceutica...+1.66+2.57%
ISISIsis Pharmaceuticals...-0.25-0.70%
PRXLPAREXEL Internationa...+0.26+0.45%
ICLRICON PLC-0.11-0.21%
Data as of 3:59pm ET, 08/19/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts